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Abstract Basic aspects in the handling of fatty acid-data
have remained largely underexposed. Of these, we aimed
to address three statistical methodological issues, by
quantitatively exemplifying their imminent confounding
impact on analytical outcomes: (1) presenting results as
relative percentages or absolute concentrations, (2) han-
dling of missing/non-detectable values, and (3) using
structural indices for data-reduction. Therefore, we reana-
lyzed an example dataset containing erythrocyte fatty acid-
concentrations of 137 recurrently depressed patients and 73
controls. First, correlations between data presented as
percentages and concentrations varied for different fatty
acids, depending on their correlation with the total fatty
acid-concentration. Second, multiple imputation of non-
detects resulted in differences in signiﬁcance compared to
zero-substitution or omission of non-detects. Third,
patients’ chain length-, unsaturation-, and peroxidation-
indices were signiﬁcantly lower compared to controls,
which corresponded with patterns interpreted from indi-
vidual fatty acid tests. In conclusion, results from our
example dataset show that statistical methodological
choices can have a signiﬁcant inﬂuence on outcomes of
fatty acid analysis, which emphasizes the relevance of:
(1) hypothesis-based fatty acid-presentation (percentages
or concentrations), (2) multiple imputation, preventing bias
introduced by non-detects; and (3) the possibility of using
(structural) indices, to delineate fatty acid-patterns thereby
preventing multiple testing.
Keywords Multiple imputation  Non-detectable values 
Undetectable  Peroxidation index (PI)  Unsaturation index
(UI)  Chain length index  Eicosapentaenoic acid (EPA) 
Docosahexaenoic acid (DHA)  Polyunsaturated fatty acids
(PUFA)  Recurrent major depressive disorder
Introduction
Clinical fatty acid (FA)-research is becoming increasingly
performed, but basic statistical methodological issues have
remained largely underexposed in scientiﬁc literature thus
far. We aim to address three of these issues in the handling
of FA-data, and provide quantitative examples of their
imminent confounding impact on results of FA-analyses,
which may confuse the understanding of the roles FA play
in (patho)physiology.
First, FA are reported in two ways: as absolute con-
centrations, or as percentages of the total FA-concentra-
tion. The implications of these different presentations have
been scarcely addressed. Importantly, the few studies that
have investigated this question showed signiﬁcant differ-
ences between both approaches [1–3]. This is conceivable,
because an increase in the percentage of one FA auto-
matically results in the decrease in the relative percentage
of another FA, even when its absolute concentration
remains unchanged [4, 5]. Nevertheless, recent research
still seems to opt rather randomly for either presentational
method.
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detectable FA-concentrations. In contrast to other research
ﬁelds [6], FA-research thus far has not addressed this
problem. Therefore, possible important analytical conse-
quences remain uninvestigated, which may potentially
cause biases in the interpretation of FA-data.
Third, because of the great number and variety of FA,
the risk exists that multiple testing induces type-I errors,
or the need for strict correction [7, 8]. A solution to this
problem could be meaningful data-reduction, decreasing
the number of tests needed. One possible way to achieve
data-reduction might be the use of indices, delineating
distinct FA-patterns by incorporating several FA-concen-
trations into one variable [9]. Examples of important
patterns in FA-research are chain length, unsaturation, and
peroxidizability of FA, because these characteristics
modulate membrane ﬂuidity and susceptibility to radical
attack and are thereby conceivably involved in the path-
ogenesis of e.g. recurrent depression [10, 11]. Using
indices, e.g. the unsaturation index (UI), chain length
index (CLI) or peroxidation index (PI) [9], would allow
testing of these more complex hypotheses on FA-patterns
involving multiple FA, thereby obviating the need to
interpret analyses of every individual FA to test your
hypothesis. Thus far, most FA-research did not correct for
multiple testing [7], and tested indices only in addition to
the individual FA. This might potentially have resulted
in type-I errors, and thereby bias in the interpretation of
FA-analyses.
In this paper, the conceivable confounding effects of
these three statistical methodological issues are exam-
ined, by providing quantitative examples in a practical
research setting, using an example dataset of FA-con-
centrations of recurrently depressed patient and healthy
controls, described previously [10]. This was done on the
basis of the following research questions: (1) what is the
inﬂuence of presentation of results in percentages or
concentrations, and how does this differ for different FA,
(2) what is the inﬂuence of the approach used for
missing/non-detectable FA-concentrations on the signiﬁ-
cances of outcome differences; and (3) what is the
inﬂuence of the use of indices for data-reduction on
outcome differences?
Materials and Methods
To investigate our research questions, we reanalyzed
an example dataset consisting of washed erythrocyte
FA-concentrations (pmol/10
6 erythrocytes) from 137 recur-
rently depressed patients and 73 age- and sex-matched
controls, determined by capillary gas chromatography,
described in more detail previously [10, 12, 13].
Percentages or Concentrations
To investigate the effects of presentational method, we
expressed FA-concentrations both in concentrations (pmol/
10
6 erythrocytes) and molecular percentages (individual
FA’s concentrations divided by the total FA-concentra-
tion). Subsequently, to quantify the difference between the
two presentational methods for each FA, we calculated the
correlation between its presentation as a percentage or as a
concentration using Pearson’s r (rabsolute–percentual; Table 1).
A rabsolute–percentual of 1.00 (perfect correlation) indicates no
difference between the two types of FA presentation, while
a rabsolute–percentual closer to zero indicates larger
differences.
To learn how, for individual FA, presentation as con-
centrations or percentages results in differential biases, we
investigated whether the difference between the two types
of presentation (expressed as rabsolute–percentual) depended on
individual FA-characteristics. Therefore, we performed a
second-level analysis exploring the relation between char-
acteristics of the different individual FA and their observed
rabsolute–percentual. We ﬁrst calculated each FA’s mean con-
centration (meanFA(i); Table 1). Subsequently, for each FA,
we calculated the absolute value (non-negative) of the
correlation between the speciﬁc FA-concentration and
the total FA-concentration for an individual subject
(|r|FA(i)-concentration–FA-total; Table 1). Finally, we determined
the inﬂuence of these individual FA-characteristics
(meanFA(i) and |r|FA(i)-concentration–FA-total) by entering these
in a stepwise linear regression model as predicting variables
with r(i)absolute–percentual (after Fisher r-to-Z transformation
[14]) as dependent variable.
Handling of Non-detectable Values
To examine the inﬂuence of the handling of non-detect-
able/missing values, we compared: (1) substituting non-
detectable values with zero, and omitting missing values;
(2) omitting both non-detectable and missing values; and
(3) using multiple imputation (MI) to estimate both non-
detectable and missing values, using the software package
Amelia II [15]. Simulation research previously demon-
strated that MI was able to provide highly valid estimations
of non-measured values, while incorporating the uncer-
tainty involved [6, 16]. MI has been used on missing
FA-concentrations before [17, 18], but not on non-detectable
FA-concentrations.
To impute non-detectable/missing values, we used
information on sex, age, marital status, educational level,
social class, Hamilton Depression Rating Scale score,
weight, length, waist and hip circumference, smoking, and
salivary cortisol and dehydroepiandrosterone sulphate,
folic acid, vitamin B6 and B12, homocysteine, and all other
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123measured FA-concentrations. In addition, for non-detect-
able values, we assigned range priors in Amelia II indi-
cating that a non-detectable FA concentration must lie
between 0.001 and the detection limit of that FA (99 %
conﬁdence).
We used differences in erythrocyte FA-concentrations
between patients and controls as example outcomes, cal-
culated with independent Student’s t tests. We compared
the results of these different approaches to handle non-
detectable/missing values to demonstrate their impact.
Calculation of Indices
To investigate the inﬂuence of the use of indices on out-
come differences we compared two methods. First, we
compared the 29 individual FA concentrations in our
Table 1 Effects of method of presentation (percentages or concentrations) and handling of non-detectable/missing values on fatty acid (FA)
results in example dataset of 137 recurrently depressed patients and 73 non-depressed controls
Presentational effects Non-detectable/missing values
Zero substitution
4 Omission
5 Imputation
6
FA rabsolute–percentual
1 Mean
2 |r|FA-total
3 Patients Controls Patients Controls Patients Controls
18:3n-3 0.96 0.83 0.38 0.84 0.81 0.85 0.83 0.83 0.81
18:4n-3 0.99 0.19 0.01 0.21
7 0.035 0.45 0.31 0.24
7 0.08
20:5n-3 0.97 3.55 0.21 3.3 3.9 3.4 3.9 3.3
9 3.9
22:5n-3 0.91 8.87 0.37 7.9
7 10.5 7.9
7 10.5 8.0
7 10.6
22:6n-3 0.95 16.75 0.29 14.8
7 20.1 14.8
7 20.1 14.9
7 20.2
18:2n-6 0.85 66.26 0.66 66 67 66 67 66 67
18:3n-6 0.98 0.52 0.10 0.57
7 0.38 0.61 0.62 0.58
7 0.41
20:3n-6 0.92 9.23 0.37 8.8
9 9.7 8.8
9 9.7 8.9
8 9.8
20:4n-6 0.62 75.22 0.72 71.5
7 81.6 72.1
7 81.6 72.0
7 81.3
22:4n-6 0.91 11.45 0.22 10.7
7 13.0 10.7
7 13.0 10.6
7 13.0
22:5n-6 0.95 1.85 0.14 1.7
7 2.1 1.7
7 2.1 1.7
7 2.1
20:2n-6 0.95 1.33 0.23 1.3 1.3 1.4 1.3 1.3 1.3
22:2n-6 0.99 0.43 0.06 0.37
7 0 0.79 ND 0.51
7 0.26
14:1n-5 0.99 0.42 0.07 0.25
7 0.60 0.57
7 1.15 0.30
7 0.65
16:1n-7 0.98 2.95 0.34 3.0
9 2.5 3.0
9 2.5 3.1
9 2.6
18:1n-7 0.86 7.63 0.72 7.5 7.9 7.6 7.9 7.5 7.9
20:1n-7 0.99 0.29 0.14 0.21 0.27 0.66
7 0.46 0.27 0.34
16:1n-9 1.00 1.27 0.19 0.9
9 1.9 0.9
8 1.9 0.93
8 1.19
18:1n-9 0.69 74.78 0.79 74 75 75 75 75 75
20:1n-9 0.94 1.21 0.31 1.2 1.2 1.2 1.3 1.2 1.2
22:1n-9 0.99 1.96 0.03 1.9 2.1 3.1
8 2.2 1.9 2.1
24:1n-9 0.93 15.47 0.29 13.3
7 19.6 13.3
7 19.6 13.3
7 19.5
20:3n-9 0.99 0.36 0.04 0.36 0.31 0.42 0.40 0.38 0.32
14:0 0.95 3.34 0.34 3.3 3.5 3.3 3.5 3.3 3.5
16:0 0.70 160.7 0.78 164
9 156 164
9 156 163
9 156
18:0 0.30 103.8 0.87 103 104 103 105 103 105
20:0 0.76 2.63 0.59 2.5
7 2.8 2.6
7 2.8 2.5
7 2.8
22:0 0.88 8.26 0.22 7.6
7 9.5 7.6
7 9.5 7.6
7 9.5
24:0 0.93 17.06 0.23 14.8
7 21.3 14.7
7 21.3 14.9
7 21.2
All correlations were calculated using Pearson’s r
1 Correlations between results presented in absolute concentrations (pmol/10
6 erythrocytes) or relative percentages (FA(i) concentration divided
by the total FA-concentration). All correlations were signiﬁcant with P\0.001
2 Mean concentrations (pmol/10
6 erythrocytes)
3 Modulus of the correlation between mean FA(i) concentration and total FA concentration
Differences in concentrations between patients and controls, calculated using independent Student’s t tests, after:
4 substitution of non-detectable
values with zero,
5 omission of non-detects, and
6 multiple imputation of missing and non-detectable values
Signiﬁcant compared to controls with
7 P\0.001,
8 P\0.01, and
9 P\0.05
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123example dataset between patients and controls using Stu-
dent’s t tests and a Bonferroni correction. We interpreted
the outcome differences to detect patterns of differences in
chain length, unsaturation or peroxidizability between
patients and controls.
As an alternative to the interpretation of these multiple
individualFA-tests,weapplieddata-reductionusingindices,
which we compared between patients and controls using
Student’s t tests. We selected three indices speciﬁcally
designed to delineate patterns in chain length, unsaturation
or peroxidizability.
1. The chain length index (CLI), providing information
about FA-chain length. We calculated the CLI by
adding the products of each FA’s concentration and the
number of carbon atoms in their carbon chain and
dividing this with the total FA-concentration;
2. The unsaturation index (UI), indicating the number of
double bounds per FA. Calculated as follows: (1 9
monoenoics ? 2 9 dienoics ? 3 9 trienoics ? 4 9
tetraenoics ? 5 9 pentaenoics ? 6 9 hexaenoics)/
total FA-concentration;
3. The peroxidation index (PI), showing FA’s suscepti-
bility to peroxidation. Calculated as follows: (0.025 9
monoenoics ? 1 9 dienoics ? 2 9 trienoics ? 4 9
tetraenoics ? 6 9 pentaenoics ? 8 9 hexaenoics)/
total FA-concentration.
Subsequently, we compared the results of these index
tests to the patterns that emerged from the interpretation of
the differences between patients and controls in the indi-
vidual FA. For this, we compared the index test results to
the individual FA-tests on multiply imputed data, and also
constructed the indices from imputed data. In this way, we
prevented missing values in the original dataset causing
many missing values among the indices, which would have
reduced statistical power.
Statistical Software
We used PASW statistics 18.0 (SPSS, Inc., 2009, Chicago,
IL, USA). MI was performed using Amelia II [15], avail-
able via the R software package [19].
Results
Correlation between Percentages and Concentrations
Table 1 shows the difference between percentages and
concentrations (expressed as rabsolute–percentual) for each FA.
Correlations ranged from 0.30 for 18:0 to 1.00 for 16:1n-9.
In the second-level analysis, linear regression showed
that meanFA(i) was associated with r(i)absolute–percentual
(b =- 0.685; t(207) =- 4.882; P\0.001). This indicates
that results presented in percentages or concentrations
differed more for FA with higher concentrations.
Furthermore, when |r|FA-concentration–FA-total was also
included in the regression model, it had an independent
negative inﬂuence on rabsolute–percentual (b =- 0.824; t(207) =
-5.486; P\0.001; Fig. 1). The inﬂuence of meanFA(i) on
rabsolute–percentual was no longer signiﬁcant. This indicates
that differences between results presented in percentages and
concentrations were signiﬁcantly greater for those FA that
have a stronger correlation with the total FA-concentration,
and that this inﬂuence explained the effect of high FA
concentrations on differences between results presented in
percentages or concentrations.
Handling of Non-detectable Values
In our example dataset, 21 patients and 8 controls had
missing FA-results due to technical reasons. The non-
detectable percentage ranged from 0 % for 16:0-24:0,
22:5n-3, 22:6n-3, C18:2n-6, 20:3n-6, 22:4n-6, 22:5n-6,
18:1n-7, 18:1n-9 and 24:1n-9, to 60.5 % for 22:2n-6. The
mean non-detectable percentage was 11.1 %.
The impact of different methods to handle missing/non-
detectable values on example outcomes are demonstrated
in Table 1. Compared to results obtained after MI, substi-
tution of non-detectable values with zero resulted in
Fig. 1 Second level analysis stepwise partial regression plot of the
relationship between |r|FA-concentration to FA-total [the absolute (non-
negative) value of the correlation between the FA-concentration and
total FA concentration for anindividual subject] with r(i)absolute–percentual
[the correlation between the presentation of a FA as a percentage or as
a concentration calculated using Pearson’s r (as an indicator of
the difference between the two presentational methods)] after Fisher
r-to-Z transformation in an example dataset of 29 FA concentration of
137 recurrently depressed patients and 73 healthy controls. Lines
representlinearﬁtand95%CI.FAfattyacid,UIunsaturationindex,CLI
chain length index, PI peroxidation index, MI multiple imputation
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123different signiﬁcance-levels for comparisons between
patients and controls. Using zero substitution, the differ-
ence between patients and controls in 20:5n-3 was not
signiﬁcant, and differences in 20:3n-6 and 16:1n-9 were
less signiﬁcant. Other FA results were comparable, with
lower concentrations for FA with non-detectable values,
reﬂecting the expected bias toward zero.
When non-detectable values were omitted and not used
in the analyses, the differences between patients and con-
trols in 18:4n-3, 20:5n-3, 18:3n-6, 20:3n-6 were less or no
longer signiﬁcant, while signiﬁcant differences in 20:1n-7
and 22:1n-9 emerged and differences in 22:2n-6 could not
be tested, all compared to results obtained after MI.
Using Indices to Describe FA Patterns
The tests on the 29 individual FA after multiple imputation
are listed in the right columns of Table 1. First, a Bon-
ferroni correction for multiple comparisons was performed
resulting in a corrected a of 0.05/29 = 0.0017. After this
correction, differences between patients and controls for
20:5n-3, 20:3n-6, 16:1n-7 and 16:0 were no longer sig-
niﬁcant. Other differences remained signiﬁcant, with lower
concentrations in patients for 22:5n-3, 22:6n-3, 20:3n-6,
20:4n-6, 22:4n-6, 22:5n-6, 14:1n-5, 16:1n-9, 24:1n-9, 20:0,
22:0 and 24:0. Concentrations of 18:4n-3 18:3n-6, 22:2n-6,
16:1n-7, and 16:0 were higher in patients compared to
controls. In analogy to our previous interpretations [10],
these results ﬁtted with patterns of reduced chain length,
unsaturation and peroxidation for FA of the patients.
After data-reduction using the CLI, UI, and PI, differ-
ences between patients and controls were calculated
(Table 2). The mean FA values for patients were less
unsaturated (P * 1.2 9 10
-18; Cohen’s d = 2.35), shorter
(P * 7.1 9 10
-19; Cohen’s d = 1.46), and less peroxidiz-
able (P * 4.0 9 10
-15; Cohen’s d = 1.83).
When comparing the index results to the results of the
multiple individual FA-tests, pattern outcomes were simi-
lar, with reduced chain length, unsaturation and peroxida-
tion for FA of patients. Using indices resulted in fewer
tests, but provided no information on differences in indi-
vidual FA concentrations between patients and controls.
Discussion
Our results indicate that: (1) presentation of FA in either
percentages or concentrations yields different results, par-
ticularly for those FA with a stronger correlation with the
total FA-concentration, (2) differences in the approach
used for non-detectable/missing values inﬂuence signiﬁ-
cance-levels of outcomes of FA-analysis, and (3) the use of
the CLI, UI and PI showed differences between patients
and controls in FA-patterns, in agreement with interpreta-
tions from individual FA-tests.
Differencesbetweendatapresentedinconcentrationsand
percentages imply that these methods are not simply inter-
changeable.Moreover,differencesbetweenpercentagesand
concentrations depended on individual FA-characteristics
(|r|FA-concentration to FA-total). This dependency could inﬂict
differential biases in individual FA results. Therefore, our
ﬁndings emphasize the importance of a hypothesis driven
choice ofwhich method touse.Percentagescouldbeusedas
a measure of the relative importance of a FA set against the
total FA concentration; while absolute concentrations could
be used for the measurement of a FA itself, independent of
the concentration of other FA [3–5, 20].
The appropriate method of presentation could theoreti-
cally differ for each research question [21]. For example,
concentrations could be most useful to distinguish
depressed patients from controls, while percentages might
predict disease progression. Therefore, the appropriate
presentation method may depend upon which presentation
is more (patho)physiologically to the research question
under investigation. However, the dearth of research
comparing both approaches so far, may—at present—
hamper the formation of a hypothesis about which method
be more (patho)physiologically relevant. If so, comparison
of both methods of presentation could provide a guideline
for future research.
Our results show that the way non-detectable/missing
values are handled could potentially bias results, because
signiﬁcance levels of differences in example outcomes
differed depending on which method was used. However, it
should be noted that not only signiﬁcances of differences,
but also magnitudes of differences determine the bias
Table 2 Mean chain length, unsaturation and peroxidation indices compared between recurrently depressed patients and controls
Patients SEM Controls SEM t df P value
Chain length index 18.32 0.0181 18.55 0.0119 10.96 226.5 *7.1 9 10
-19
Unsaturation index 1.29 0.0068 1.39 0.0059 11.14 90.21 *1.2 9 10
-18
Peroxidation index 1.10 0.0093 1.22 0.0090 9.241 101.5 *4.0 9 10
-15
All differences were calculated using independent Student’s t test on indices of 137 recurrently depressed patients and 73 controls
SEM standard error of the mean, df degrees of freedom
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123introduced. Nevertheless, if non-detects occur, knowledge
of the way they were handled, and discussion of any pos-
sible bias that may be inﬂicted as such, could prevent
interpretation errors. Because other research ﬁelds already
showed superiority of MI compared to other ways of
handling non-detectable/missing values [6], this may soon
be adapted as the preferred method to handle missing/non-
detectable FA-concentrations as well.
By applying data reduction using indices—the CLI, UI
and PI—we tested differences between patients and con-
trols in FA-patterns. Index results were similar to the
interpretation of the multiple tests on individual FA [10].
This suggests that indices could provide meaningful data-
reduction in FA research. Furthermore, from a statistical
viewpoint, the use of indices enabled us to test pattern
hypotheses more efﬁciently by using only one outcome
variable (CLI, UI or PI), instead of tests of many individual
FA. This precluded the need for correction for multiple
tests. In our example dataset this was not of speciﬁc ana-
lytical concern, because differences in individual FA-tests
were large and mostly survived the Bonferroni correction.
Nevertheless, this advantage may be beneﬁcial in smaller
samples or in diseased populations with smaller differences
compared with controls. In addition, the indices facilitated
quantitative testing of pattern hypotheses, in contrast to
the qualitative interpretation of the individual FA tests.
The disadvantage of integrating information on multiple
FA-concentrations in one index, could be that it might
undesirably simplify the underlying complexity of
FA-metabolism. In such situations the relevance of an
individual FA could be obscured, because differences in
individual FA are not tested.
Whether indices should be used in FA-research seems to
depend on the hypothesis under investigation. If FA are
analyzed in order to test a pattern [e.g. membrane ﬂuidity;
unsaturation or peroxidizability; estimated enzyme activity;
(inﬂammation regulating) FA ratios], indices could be used
to ﬁrst test this general pattern hypothesis. Subsequently,
based on the index results, new speciﬁc hypotheses con-
cerning selected individual FA could be tested. This would
reduce the risk for type-I errors, or the need for strict cor-
rection for multiple testing [8]. A recent example of the
possible usefulness of applying indices is the observation of
bimodal distributions of FA unsaturation and chain length
patterns in recurrently depressed patients [22]. However, if
FAareanalyzedtotestahypothesisconcerningaspeciﬁcFA
(e.g. EPA), indices have no use, and should not be tested
additionally since this would only increase the problem of
multiple testing. Future studies are needed to further clarify
the applicability of indices in FA-research.
Some additional limitations should be noted. The
examples of the possible inﬂuences of the presented sta-
tistical methodological issues have been presented on the
basis of only one dataset. However, although the size of the
biasing effects may differ between different datasets, the
basic principles of the issues addressed concern analysis of
FA data in general. Second, our example dataset has a
moderate sample size when compared to epidemiological
studies. This could have inﬂuenced the stability of corre-
lation coefﬁcients, and therefore the results. Third, the data
presented only concern these three statistical methodolog-
ical issues, and do not investigate other important factors
that may also inﬂuence results, e.g. chemical analytical
methods, and the nature of the sample (tissue, cell type,
lipid fraction, e.g. cholesteryl esters, triacylglycerol,
phospholipids) [4]. Finally, because differences in outcome
measures were large in our example dataset, the disad-
vantages of multiple testing—and thereby the advantages
of data reduction—could not be clearly exempliﬁed and
remain to be further explored in different datasets.
Nevertheless,ourstudyaddressesrecurrentbasicissuesin
practicalFAresearch.Usingasecond-levelanalysiswewere
able to quantitatively demonstrate the consequences of the
various methods ofpresentation. In addition, we suggested a
novel way to handle non-detectable FA-values, using MI.
Finally, we showed, to our knowledge for the ﬁrst time, that
indices could be used to delineate differences in FA patterns
between depressed patients and controls.
In conclusion, a hypothesis-based choice of the method of
FA-presentation (percentages or concentrations) could pre-
ventbiasinfutureFA-research.Ifitisnotclearwhichmethod
ispreferableapriori,comparisonofbothmethodscouldguide
subsequent investigations. Furthermore, MI might prevent
bias potentially inducible by missing/non-detectable values.
Finally, indices could assist theory based data-reduction,
thereby preventing type-I errors associated with multiple
testing. Awareness and cautious handling of these statistical
methodological issues in future FA-research may further
improve interpretation of FA-analyses, and thereby deepen
the understanding of the roles FA play in health and disease.
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